DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 119 filers reported holding DENALI THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 1.75 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $303,261 | -30.1% | 14,700 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $433,797 | +66.6% | 14,700 | +30.1% | 0.00% | – |
| Q1 2023 | $260,352 | -17.2% | 11,300 | 0.0% | 0.00% | -100.0% |
| Q4 2022 | $314,253 | -9.4% | 11,300 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $347,000 | -20.4% | 11,300 | -23.8% | 0.00% | – |
| Q2 2022 | $436,000 | -24.0% | 14,820 | -16.8% | 0.00% | – |
| Q1 2022 | $574,000 | -64.5% | 17,820 | -50.7% | 0.00% | -100.0% |
| Q4 2021 | $1,615,000 | +70.9% | 36,145 | +92.9% | 0.00% | 0.0% |
| Q3 2021 | $945,000 | -48.6% | 18,735 | -20.1% | 0.00% | -50.0% |
| Q2 2021 | $1,840,000 | +37.3% | 23,455 | 0.0% | 0.00% | +100.0% |
| Q1 2021 | $1,340,000 | -50.4% | 23,455 | -27.3% | 0.00% | -66.7% |
| Q4 2020 | $2,702,000 | +368.3% | 32,260 | -2.7% | 0.00% | +200.0% |
| Q4 2019 | $577,000 | -39.4% | 33,154 | -45.8% | 0.00% | 0.0% |
| Q3 2019 | $952,000 | -25.2% | 61,216 | -0.1% | 0.00% | 0.0% |
| Q2 2019 | $1,272,000 | -45.1% | 61,261 | -38.6% | 0.00% | -50.0% |
| Q1 2019 | $2,318,000 | +24.4% | 99,822 | +9.4% | 0.00% | 0.0% |
| Q4 2018 | $1,864,000 | -61.6% | 91,204 | -59.2% | 0.00% | -50.0% |
| Q3 2018 | $4,854,000 | +34.4% | 223,280 | -5.7% | 0.00% | 0.0% |
| Q2 2018 | $3,611,000 | -22.4% | 236,790 | +0.2% | 0.00% | 0.0% |
| Q1 2018 | $4,653,000 | +49.1% | 236,290 | +18.4% | 0.00% | +100.0% |
| Q4 2017 | $3,121,000 | – | 199,545 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crestline Management, LP | 5,960,732 | $122,969,901 | 14.32% |
| ARCH Venture Management, LLC | 693,749 | $14,312,042 | 9.30% |
| Flagship Pioneering Inc. | 2,619,968 | $54,049,940 | 3.92% |
| Casdin Capital, LLC | 1,300,000 | $26,819,000 | 2.97% |
| Yiheng Capital Management, L.P. | 1,150,684 | $23,738,611 | 1.21% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 154,000 | $3,172,400 | 1.07% |
| SECTORAL ASSET MANAGEMENT INC | 254,941 | $5,259,433 | 1.02% |
| Temasek Holdings (Private) Ltd | 6,895,992 | $142,264,315 | 0.85% |
| Clarius Group, LLC | 378,262 | $7,803,545 | 0.74% |
| Artal Group S.A. | 802,899 | $16,564 | 0.71% |